BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 28169239)

  • 1. Modified mismatch polymerase chain reaction-restriction fragment length polymorphism detected mutations in codon 12 and 13 of exon 2 of K-
    Faleel FD; Zoysa MI; Lokuhetti MD; Gunawardena YI; Chandrasekharan VN; Dassanayake RS
    J Cancer Res Ther; 2016; 12(4):1272-1277. PubMed ID: 28169239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. K-ras codon 12 and 13 mutations are correlated with differential patterns of tumor cell dissemination in colorectal cancer patients.
    Conzelmann M; Linnemann U; Berger MR
    Int J Oncol; 2004 Jun; 24(6):1537-44. PubMed ID: 15138598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitive detection of K-ras mutations augments diagnosis of colorectal cancer metastases in the liver.
    Schimanski CC; Linnemann U; Berger MR
    Cancer Res; 1999 Oct; 59(20):5169-75. PubMed ID: 10537293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of isolated tumor cells by polymerase chain reaction-restriction fragment length polymorphism for K-ras mutations in tissue samples of 199 colorectal cancer patients.
    Dieterle CP; Conzelmann M; Linnemann U; Berger MR
    Clin Cancer Res; 2004 Jan; 10(2):641-50. PubMed ID: 14760087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. K-ras gene mutation status in colorectal cancer: comparative analysis of pyrosequencing and PCR-RFLP.
    Dobre M; Comănescu M; Arsene D; Iosif C; Bussolati G
    Rom J Morphol Embryol; 2013; 54(3):567-74. PubMed ID: 24068405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of codon 61 point mutations of the K-ras gene in lung and colorectal cancers by enriched PCR.
    Toyooka S; Tsukuda K; Ouchida M; Tanino M; Inaki Y; Kobayashi K; Yano M; Soh J; Kobatake T; Shimizu N; Shimizu K
    Oncol Rep; 2003; 10(5):1455-9. PubMed ID: 12883723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The balanced induction of K-ras codon 12 and 13 mutations in mucosa differs from their ratio in neoplastic tissues.
    Kraus MC; Seelig MH; Linnemann U; Berger MR
    Int J Oncol; 2006 Oct; 29(4):957-64. PubMed ID: 16964391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discrepancies between the K-ras mutational status of primary colorectal cancers and corresponding liver metastases are found in codon 13.
    Kawamata H; Yamashita K; Kojo K; Ushiku H; Ooki A; Watanabe M
    Genomics; 2015 Aug; 106(2):71-5. PubMed ID: 26026309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of K-ras mutations in stools of patients with colorectal cancer by mutant-enriched PCR.
    Nollau P; Moser C; Weinland G; Wagener C
    Int J Cancer; 1996 May; 66(3):332-6. PubMed ID: 8621253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of K-ras mutations with liver metastases from colorectal carcinoma.
    Tsunoda A; Iijima T; Tsunoda Y; Nakao K; Miyaki M; Kusano M
    Anticancer Res; 2004; 24(4):2471-6. PubMed ID: 15330200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological Associations of K-RAS and N-RAS Mutations in Indonesian Colorectal Cancer Cohort.
    Levi M; Prayogi G; Sastranagara F; Sudianto E; Widjajahakim G; Gani W; Mahanadi A; Agnes J; Khairunisa BH; Utomo AR
    J Gastrointest Cancer; 2018 Jun; 49(2):124-131. PubMed ID: 28044264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
    Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
    Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide nucleic acid clamp PCR: a novel K-ras mutation detection assay for colorectal cancer micrometastases in lymph nodes.
    Taback B; Bilchik AJ; Saha S; Nakayama T; Wiese DA; Turner RR; Kuo CT; Hoon DS
    Int J Cancer; 2004 Sep; 111(3):409-14. PubMed ID: 15221969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the K-ras/B-raf/Erk signal cascade, p53 and CMAP as markers for tumor progression in colorectal cancer patients.
    Georgieva M; Krasteva M; Angelova E; Ralchev K; Dimitrov V; Bozhimirov S; Georgieva E; Berger MR
    Oncol Rep; 2008 Jul; 20(1):3-11. PubMed ID: 18575712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Correlation analysis between abundance of K-ras mutation in plasma free DNA and its correlation with clinical outcome and prognosis in patients with metastatic colorectal cancer].
    Bai YQ; Liu XJ; Wang Y; Ge FJ; Zhao CH; Fu YL; Lin L; Xu JM
    Zhonghua Zhong Liu Za Zhi; 2013 Sep; 35(9):666-71. PubMed ID: 24332053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A modified mutagenic PCR-RFLP method for K-ras codon 12 and 13 mutations detection in NSCLC patients.
    Hatzaki A; Razi E; Anagnostopoulou K; Iliadis K; Kodaxis A; Papaioannou D; Labropoulos S; Vasilaki M; Kosmidis P; Saetta A; Mihalatos M; Nasioulas G
    Mol Cell Probes; 2001 Oct; 15(5):243-7. PubMed ID: 11735295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of chemokine receptor CCR5 correlates with the presence of hepatic molecular metastases in K-ras positive human colorectal cancer.
    Schimanski CC; Moehler M; Gockel I; Zimmermann T; Lang H; Galle PR; Berger MR
    J Cancer Res Clin Oncol; 2011 Jul; 137(7):1139-45. PubMed ID: 21468700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A simple method of detecting K-ras point mutations in stool samples for colorectal cancer screening using one-step polymerase chain reaction/restriction fragment length polymorphism analysis.
    Nishikawa T; Maemura K; Hirata I; Matsuse R; Morikawa H; Toshina K; Murano M; Hashimoto K; Nakagawa Y; Saitoh O; Uchida K; Katsu K
    Clin Chim Acta; 2002 Apr; 318(1-2):107-12. PubMed ID: 11880119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. K-Ras mutations and treatment outcome in colorectal cancer patients receiving exclusive fluoropyrimidine therapy.
    Etienne-Grimaldi MC; Formento JL; Francoual M; François E; Formento P; Renée N; Laurent-Puig P; Chazal M; Benchimol D; Delpero JR; Letoublon C; Pezet D; Seitz JF; Milano G
    Clin Cancer Res; 2008 Aug; 14(15):4830-5. PubMed ID: 18676755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of K-ras codon 12 mutations in human feces and ages of patients with colorectal cancer (CRC).
    Chien CC; Chen SH; Liu CC; Lee CL; Yang RN; Yang SH; Huang CJ
    Transl Res; 2007 Feb; 149(2):96-102. PubMed ID: 17240321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.